Beyond Borders 2014 – Overview of the Biotechnology Landscape
Keywords:Biotechnology, Business angels, Life sciences, Medical technology, Venture capital
AbstractThe global biotechnology industry rebounded strongly in 2013. Public companies achieved double-digit revenue growth and there was a sharp rise in funds. Product successes have boosted revenues, drawn investors and motivated large companies to invest strongly in R&D. However, much of the industry's growth was driven by a relatively small group of commercial stage companies, increasing the urgency for the rest of the industry to achieve greater efficiency in their drug development efforts.
How to Cite
J. Zürcher, Chimia 2014, 68, 840, DOI: 10.2533/chimia.2014.840.
Copyright (c) 2014 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.